In the John Oliver opioids segment, OxyContin sells more per year than which of the following?

Prepare for the Alcohol Drugs and Society Test. Engage with quizzes and flashcards, each with hints and explanations. Ace your exam!

Multiple Choice

In the John Oliver opioids segment, OxyContin sells more per year than which of the following?

Explanation:
The main idea being tested is the sheer scale of OxyContin’s sales compared with other well-known drugs, illustrating how profitable opioids were relative to other popular medications. In the John Oliver segment, he emphasizes that OxyContin brings in more in annual sales than Viagra, highlighting just how large opioid profits were at that time. This comparison helps show the extraordinary market impact of the opioid crisis era. Viagra is used here as the benchmark for a blockbuster that many would assume sells more than most drugs, yet the segment makes the point that OxyContin’s yearly revenue surpassed it. The other drugs listed—ADHD medications, Paxil, and Zyrtec—are also major sellers, but the specific comparison highlighted in the segment is OxyContin vs Viagra, which is why that option is the best choice.

The main idea being tested is the sheer scale of OxyContin’s sales compared with other well-known drugs, illustrating how profitable opioids were relative to other popular medications. In the John Oliver segment, he emphasizes that OxyContin brings in more in annual sales than Viagra, highlighting just how large opioid profits were at that time. This comparison helps show the extraordinary market impact of the opioid crisis era.

Viagra is used here as the benchmark for a blockbuster that many would assume sells more than most drugs, yet the segment makes the point that OxyContin’s yearly revenue surpassed it. The other drugs listed—ADHD medications, Paxil, and Zyrtec—are also major sellers, but the specific comparison highlighted in the segment is OxyContin vs Viagra, which is why that option is the best choice.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy